研究成果
年分
作者
期刊
研究名稱
2024
Chang HC, Kuo L, Sung SH, Niu DM, Yu WC*.
J. Am. Soc. Echocardiogr. 2024; 37(8):787-796. (IF: 5.400)
Prognostic Implications of Left Ventricular Hypertrophy and Mechanical Function in Fabry Disease: A Longitudinal Cohort Study.
2024
Chang HY, Lee CM, Hung CL, Sung SH, Lin TH, Wu YW, Hwang JJ, Chen WJ, Wang CC*.
Acta Cardiol. Sin. 2024; 40(2): 235-241. (IF: 1.900)
Taiwan Society of Cardiology Heart Failure Registry 2020: Rationale and Design.
2024
Chao TH*, Lin TH, Cheng C, Wu YW, Ueng KC, Wu YJ, Lin WW, Leu HB, Cheng HM,... , Lu YW, Lin PL, Wang CP, Ko YS, Chiang CE, Hou CJY, Wang TD, Lin YH, Huang PH, Chen WJ.
Acta Cardiol. Sin. 2024; 40(6): 669-715. (IF: 1.800)
2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part II.
2024
Chao TH*, Lin TH, Cheng C, Wu YW, Ueng KC, Wu YJ, Lin WW, Leu HB, Cheng HM, Huang CC, Wu CC, Lin CF, Chang WT, Pan WH, Chen PR, Ting KH, Su CH, Chu CS, Chien KL, Yen HW, Wang YC, Su TC, Liu PY, Chang HY, Chen PW, Jimmy JM, ...
Acta Cardiol. Sin. 2024; 40(5): 544-568. (IF: 1.800)
2024 Update of the TSOC Expert Consensus of Disease.
2024
Chao TF, Potpara TS, Lip GYH.
Lancet Reg. Health-Eur. 2024; 37 (11):1765-1774. (IF:13.600)
Atrial fibrillation: stroke prevention.
2024
Chao TF*, Yeh YH, Chan YH, Lin FJ, Chen TH, Pan KL, Lin JC, Lin YJ, Chen SA.
Thromb. Haemost.2024; 124(01): 61-68. (IF: 5.500)
The Report of Community-Based and Government-Endorsed Screening Program of Atrial Fibrillation in Taiwan.
2024
Chen KL, Chou RH*, Chang CC, Kuo CS, Wei JH, Huang PH*, Lin SJ.
PLoS One. 2024; 19(4): e0296863. (IF:5.300)
The high-density lipoprotein cholesterol (HDL-C)-concentration-dependent association between anti-inflammatory capacity and sepsis: A single-center cross-sectional study.
2024
Chen YT, Lin CC, Huang PH*, Li SY*.
J. Formos. Med. Assoc. 2024; 123(5): 606-612. (IF: 2.600)
Comparative analysis of hemodialysis and peritoneal dialysis on the risk of new onset diabetes mellitus.
2024
Chiang CH, Lan TY, Hsieh JH, Lin SC, Chen JW, Chang TT*.
J. Agric. Food Chem. 2024;72(31): 17444-17454. (IF: 5.700)
Diosgenin Reduces Acute Kidney Injury and Ameliorates the Progression to Chronic Kidney Disease by Modifying the NOX4/p65 Signaling Pathways.
2024
Chang GJ, Chen WJ*, Hsu YJ, Chen YH.
J. Am. Heart Assoc. 2024; 13(22): (IF:5.000)
Empagliflozin Attenuates Neointima Formation After Arterial Injury and Inhibits Smooth Muscle Cell Proliferation and Migration by Suppressing Platelet-Derived Growth Factor-Related Signaling.